# Assertio Holdings, Inc. (ASRT) — merger [pending]
Source: sec.gov · situation sit_a5adbf30fac1d54d83f4 · public 3765507502594536382 · retrieved 2026-08-20T13:37:17.810Z

## Overview
If the markets or patient subsets that we are targeting are not as significant as we estimate, or if we are unable to maintain and grow our market share or are unable to maintain or expand our pricing, we may not generate significant growth in revenues from sales of ROLVEDON.

## Key dates
- Announced 2026-05-18

## Timeline
- 2026-05-18 · SC 14D9 (0001104659-26-063278): SC 14D9 - Assertio Holdings, Inc. — *If the markets or patient subsets that we are targeting are not as significant as we estimate, or if we are unable to maintain and grow our market share or are unable to maintain or expand our pricing, we may not generate significant growth in revenues from sales of ROLVEDON.* Prior to Assertio's entry into the Merger Agreement, Assertio entered into that certain Agreement and Plan of Merger, dated as of April 8, 2026 (the "Original Garda Merger Agreement"), with Garda Therapeutics, Inc.
  https://www.sec.gov/Archives/edgar/data/1808665/0001104659-26-063278.txt
- 2026-06-16 · SC 14D9/A (0001104659-26-074311): SC 14D9/A - Assertio Holdings, Inc. — *If the markets or patient subsets that we are targeting are not as significant as we estimate, or if we are unable to maintain and grow our market share or are unable to maintain or expand our pricing, we may not generate significant growth in revenues from sales of ROLVEDON.*
  https://www.sec.gov/Archives/edgar/data/1808665/0001104659-26-074311.txt

## Citations
- 0001104659-26-063278 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000110465926063278
- 0001104659-26-074311 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000110465926074311